1. Home
  2. BOF vs ABP Comparison

BOF vs ABP Comparison

Compare BOF & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BranchOut Food Inc.

BOF

BranchOut Food Inc.

HOLD

Current Price

$3.48

Market Cap

33.2M

ML Signal

HOLD

ABP

Abpro Holdings Inc

HOLD

Current Price

$5.78

Market Cap

18.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOF
ABP
Founded
2017
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.2M
18.8M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
BOF
ABP
Price
$3.48
$5.78
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
87.2K
27.8K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,218,127.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
72.85
50.00
52 Week Low
$1.53
$4.55
52 Week High
$3.62
$153.90

Technical Indicators

Market Signals
Indicator
BOF
ABP
Relative Strength Index (RSI) 59.59 57.16
Support Level $3.11 $5.41
Resistance Level $3.62 $6.19
Average True Range (ATR) 0.23 0.58
MACD 0.02 -0.26
Stochastic Oscillator 77.88 32.10

Price Performance

Historical Comparison
BOF
ABP

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

About ABP Abpro Holdings Inc

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Share on Social Networks: